At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 12 enrolled
Drug / intervention
Dulaglutide +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 4 Study to Evaluate Glucodynamic Effects of Dulaglutide in Japanese Patients With Type 2 Diabetes Mellitus
In Brief
A Phase 4 clinical trial evaluating Dulaglutide and Placebo for Type 2 Diabetes. Completed, enrolled 12 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the glucodynamic effects of dulaglutide in Japanese participants with type 2 diabetes mellitus.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes
CountriesJapan
Collaborators--
Timeline
Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedOct 2017
Enrollment StartOct 2017
Primary CompletionFeb 2018
TodayJul 2026
First PostedOct 20, 2017
Enrollment StartOct 28, 2017
Primary CompletionFeb 28, 2018
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 8.7 years ago
Interventions
Dulaglutidedrug
Administered SC
Placebodrug
Administered SC